Ms. Samira Sakhia reports

NOTICE OF KNIGHT THERAPEUTICS' FOURTH QUARTER AND YEAR END 2023 RESULTS CONFERENCE CALL

Knight Therapeutics Inc. will release its fourth quarter and year-end 2023 financial results on Thursday, March 21, 2024, prior to market open. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call.

Conference call and webcast details

Date:  Thursday, March 21, 2024

Time:  8:30 a.m. ET

Toll-free:  1-888-664-6383

International:  1-416-764-8650

Listen-only webcast:  visit the company's website

Replay (available for 30 days):  visit the company's website

About Knight Therapeutics Inc.

Headquartered in Montreal, Canada, Knight Therapeutics is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Knight's Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM.

We seek Safe Harbor.